Hubei Biocause Pharmaceutical000627 
$0.41-6.19%24h
-6.19%24h
Global rank5173
Market cap$2.01B
Change 7d46.94%
YTD Performance1.05%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield9.5%
Market capitalization of Hubei Biocause Pharmaceutical (000627)
As of December 2024, Hubei Biocause Pharmaceutical has a market cap of $2.01B. This makes Hubei Biocause Pharmaceutical the world's 5173th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Hubei Biocause Pharmaceutical from 1996 to 2024
-
Value:-
Market cap history of Hubei Biocause Pharmaceutical from 1996 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $1.84B | -7.39% |
| 2023 | $1.98B | -10.13% |
| 2022 | $2.20B | -4.53% |
| 2021 | $2.31B | -32.03% |
| 2020 | $3.40B | -30.82% |
| 2019 | $4.91B | 25.49% |
| 2018 | $3.91B | -29.87% |
| 2017 | $5.58B | 4.58% |
| 2016 | $5.34B | -28.90% |
| 2015 | $7.51B | 162.44% |
| 2014 | $2.86B | 56.49% |
| 2013 | $1.83B | -6.76% |
| 2012 | $1.96B | -1.40% |
| 2011 | $1.99B | -43.11% |
| 2010 | $3.50B | 24.24% |
| 2009 | $2.81B | 129.54% |
| 2008 | $1.23B | -70.98% |
| 2007 | $4.22B | 279.66% |
| 2006 | $1.11B | 56.91% |
| 2005 | $709.08M | -15.01% |
| 2004 | $834.34M | -12.84% |
| 2003 | $957.21M | -67.12% |
| 2002 | $2.91B | -15.39% |
| 2001 | $3.44B | 16.09% |
| 2000 | $2.96B | 92.20% |
| 1999 | $1.54B | 145.09% |
| 1998 | $629.32M | -25.83% |
| 1997 | $848.51M | -5.71% |
| 1996 | $899.94M | - |
000627 Market Cap Today is $2.01B -6.19% - 9 Dec 2024
View largest stocks by market cap 
